Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Asset Writedowns and Impairment (2016 - 2026)

Angiodynamics' Asset Writedowns and Impairment history spans 17 years, with the latest figure at $317000.0 for Q1 2026.

  • For Q1 2026, Asset Writedowns and Impairment rose 734.21% year-over-year to $317000.0; the TTM value through Feb 2026 reached $266000.0, down 51.99%, while the annual FY2025 figure was $173000.0, 86.95% down from the prior year.
  • Asset Writedowns and Impairment reached $317000.0 in Q1 2026 per ANGO's latest filing, up from -$235000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $3.4 million in Q1 2024 to a low of -$320000.0 in Q4 2023.
  • Average Asset Writedowns and Impairment over 5 years is $342933.3, with a median of $76000.0 recorded in 2025.
  • The largest YoY upside for Asset Writedowns and Impairment was 2588.24% in 2022 against a maximum downside of 920.0% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$87000.0 in 2022, then plummeted by 267.82% to -$320000.0 in 2023, then soared by 112.19% to $39000.0 in 2024, then plummeted by 702.56% to -$235000.0 in 2025, then skyrocketed by 234.89% to $317000.0 in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Asset Writedowns and Impairment are $317000.0 (Q1 2026), -$235000.0 (Q4 2025), and $108000.0 (Q3 2025).